These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 446854)

  • 1. Role of monoamine oxidase isoenzymes in rat motor activity after rubidium chloride treatment [proceedings].
    Acobettro RI; Ribas B; Ortiz T; Torres JT
    Biochem Soc Trans; 1979 Jun; 7(3):534-6. PubMed ID: 446854
    [No Abstract]   [Full Text] [Related]  

  • 2. The turnover of the A- and B-forms of monoamine oxidase in rat liver.
    Corte LD; Tipton KF
    Biochem Pharmacol; 1980 Mar; 29(6):891-5. PubMed ID: 7387706
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase inhibits mitochondrial respiration.
    Cohen G; Kesler N
    Ann N Y Acad Sci; 1999; 893():273-8. PubMed ID: 10672247
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase-III. Further studies of inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 7. Cimoxatone is a reversible tight-binding inhibitor of the A form of rat brain monoamine oxidase.
    Fowler CJ; Strolin Benedetti M
    J Neurochem; 1983 Feb; 40(2):510-3. PubMed ID: 6822834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate selectivity of type A and type B monoamine oxidase in rat brain.
    Kinemuchi H; Wakui Y; Kamijo K
    J Neurochem; 1980 Jul; 35(1):109-15. PubMed ID: 6778959
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
    Fuentes JA; Neff NH
    Neuropharmacology; 1975 Nov; 14(11):819-25. PubMed ID: 1207877
    [No Abstract]   [Full Text] [Related]  

  • 11. Substrate specificity of the different forms of monoamine oxidase in rat liver mitochondria.
    Ekstedt B
    Biochem Pharmacol; 1976 May; 25(10):1133-8. PubMed ID: 938537
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoacylcadaverines as substrates for both monoamine oxidase and diamine oxidase; low rates of activity.
    Suzuki O; Matsumoto T; Oya M; Katsumata Y; Stepita-Klauco M
    Experientia; 1980 May; 36(5):535-7. PubMed ID: 6769699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of central monoamine oxidase by imidazoline2 site-selective ligands.
    Lalies MD; Hibell A; Hudson AL; Nutt DJ
    Ann N Y Acad Sci; 1999 Jun; 881():114-7. PubMed ID: 10415906
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase substrates and substrate affinity.
    Domino EF
    Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase activity at different levels of rat spinal cord [proceedings].
    George AJ
    Br J Pharmacol; 1977 Jun; 60(2):308P. PubMed ID: 880473
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain.
    Campbell IC; Robinson DS; Lovenberg W; Murphy DL
    J Neurochem; 1979 Jan; 32(1):49-55. PubMed ID: 32233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.